Notice2026-01412

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 26, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 16 (Monday, January 26, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 16 (Monday, January 26, 2026)]
[Notices]
[Pages 3209-3210]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-01412]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Clinical Care and Interventions for Substance Use 
Disorder, Prevention, and Treatment of Addiction.
    Date: February 25-26, 2026.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Cristina Lyn Reitz-Krueger, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-480-2060, 
<a href="/cdn-cgi/l/email-protection#e586978c96918c8b84cb97808c919fc88e979080828097a58b8c8dcb828a93"><span class="__cf_email__" data-cfemail="5330213a20273a3d327d21363a27297e38212636343621133d3a3b7d343c25">[email&#160;protected]</span></a>.

    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group; Emerging Imaging 
Technologies and Applications Study Section.
    Date: February 27, 2026.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Zheng Li, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-594-3385, 
<a href="/cdn-cgi/l/email-protection#23594b464d440d4f4a10634d4a4b0d444c55"><span class="__cf_email__" data-cfemail="d3a9bbb6bdb4fdbfbae093bdbabbfdb4bca5">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Transition to Independence.
    Date: March 5, 2026.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Delia Tang, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 240-479-8238, 
<a href="/cdn-cgi/l/email-protection#ec988d828b88ac818d8580c2828584c28b839a"><span class="__cf_email__" data-cfemail="a1d5c0cfc6c5e1ccc0c8cd8fcfc8c98fc6ced7">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; U2C-TL1 Institutional Network Applications for Promoting 
Kidney, Urologic, and Hematologic Research Training.
    Date: March 11, 2026.
    Time: 9:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jason D. Hoffert, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-496-9010, 
<a href="/cdn-cgi/l/email-protection#8ce6edffe3e2a2e4e3eaeae9fef8cce2e5e4a2ebe3fa"><span class="__cf_email__" data-cfemail="e28883918d8ccc8a8d8484879096a28c8b8acc858d94">[email&#160;protected]</span></a>.

    Name of Committee: Interdisciplinary Molecular Sciences and 
Training Integrated Review Group; Cellular and Molecular 
Technologies Study Section.
    Date: March 11-12, 2026.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Tatiana V. Cohen, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-455-2364, 
<a href="/cdn-cgi/l/email-protection#453124312c242b246b262a2d202b052b2c2d6b222a33"><span class="__cf_email__" data-cfemail="b7c3d6c3ded6d9d699d4d8dfd2d9f7d9dedf99d0d8c1">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Exploratory Research in Cancer Prevention and 
Therapeutics (R21).
    Date: March 11, 2026.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.

[[Page 3210]]

    Meeting Format: Virtual Meeting.
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-435-0000, 
<a href="/cdn-cgi/l/email-protection#a9c3cfc8c7cee9c4c8c0c587c7c0c187cec6df"><span class="__cf_email__" data-cfemail="8be1edeae5eccbe6eae2e7a5e5e2e3a5ece4fd">[email&#160;protected]</span></a>.

    Name of Committee: Vascular and Hematology Integrated Review 
Group; Atherosclerosis and Vascular Inflammation Study Section.
    Date: March 12, 2026.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Natalia Komissarova, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD 
20892, 301-435-1206, <a href="/cdn-cgi/l/email-protection#4b2024262238382a390b262a222765252223652c243d"><span class="__cf_email__" data-cfemail="bbd0d4d6d2c8c8dac9fbd6dad2d795d5d2d395dcd4cd">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Immunology-Oncology.
    Date: March 13, 2026.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Jing Chen, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-435-5000, 
<a href="/cdn-cgi/l/email-protection#197a717c777370777e597478707537777071377e766f"><span class="__cf_email__" data-cfemail="debdb6bbb0b4b7b0b99eb3bfb7b2f0b0b7b6f0b9b1a8">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 21, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-01412 Filed 1-23-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 26, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.